BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 11585923)

  • 1. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
    Elowe S; Holland SJ; Kulkarni S; Pawson T
    Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
    Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
    EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
    Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
    Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
    Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
    FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH; Zisch AH; Dodelet VC; Pasquale EB
    Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion.
    Dail M; Richter M; Godement P; Pasquale EB
    J Cell Sci; 2006 Apr; 119(Pt 7):1244-54. PubMed ID: 16522685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
    Hanafusa H; Torii S; Yasunaga T; Nishida E
    Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.
    Tanaka M; Ohashi R; Nakamura R; Shinmura K; Kamo T; Sakai R; Sugimura H
    EMBO J; 2004 Mar; 23(5):1075-88. PubMed ID: 14988728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
    Zisch AH; Pazzagli C; Freeman AL; Schneller M; Hadman M; Smith JW; Ruoslahti E; Pasquale EB
    Oncogene; 2000 Jan; 19(2):177-87. PubMed ID: 10644995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
    Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
    Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells.
    Schmid RS; Graff RD; Schaller MD; Chen S; Schachner M; Hemperly JJ; Maness PF
    J Neurobiol; 1999 Mar; 38(4):542-58. PubMed ID: 10084688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of extracellular signal-regulated kinase activity by p120 RasGAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation.
    Koehler JA; Moran MF
    Cell Growth Differ; 2001 Nov; 12(11):551-61. PubMed ID: 11714636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
    Tong J; Elowe S; Nash P; Pawson T
    J Biol Chem; 2003 Feb; 278(8):6111-9. PubMed ID: 12486127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling of cAMP/PKA and MAPK signaling in neuronal cells is dependent on developmental stage.
    Vogt Weisenhorn DM; Roback LJ; Kwon JH; Wainer BH
    Exp Neurol; 2001 May; 169(1):44-55. PubMed ID: 11312557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
    Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases.
    Aoki J; Katoh H; Yasui H; Yamaguchi Y; Nakamura K; Hasegawa H; Ichikawa A; Negishi M
    Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):365-9. PubMed ID: 10333476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.